$VRTX
VERTEX PHARMACEUTICALS INC / MA

2020 Q3 Form 10-Q Financial Statement

#000087532020000043 Filed on October 30, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q4 2019 Q3
Revenue $1.538B $1.413B $949.8M
YoY Change 61.95% 62.42% 21.07%
Cost Of Revenue $186.2M $185.0M $131.9M
YoY Change 41.14% 51.29% 18.57%
Gross Profit $1.352B $1.228B $817.9M
YoY Change 65.31% 64.25% 21.48%
Gross Profit Margin 87.9% 86.91% 86.11%
Selling, General & Admin $184.6M $195.3M $159.7M
YoY Change 15.58% 27.46% 16.3%
% of Gross Profit 13.65% 15.9% 19.52%
Research & Development $493.5M $480.0M $555.9M
YoY Change -11.23% 9.62% 68.21%
% of Gross Profit 36.5% 39.08% 67.97%
Depreciation & Amortization $26.70M $26.20M $25.90M
YoY Change 3.09% 39.36% 34.9%
% of Gross Profit 1.97% 2.13% 3.17%
Operating Expenses $678.0M $675.3M $715.6M
YoY Change -5.25% 14.24% 52.97%
Operating Profit $672.2M $551.5M $99.33M
YoY Change 576.75% 331.77% -51.7%
Interest Expense $13.86M $14.25M $14.55M
YoY Change -4.76% -23.98% -22.14%
% of Operating Profit 2.06% 2.58% 14.65%
Other Income/Expense, Net $84.39M $127.4M -$31.75M
YoY Change -365.81% -240.82% -47.95%
Pretax Income $745.9M $677.0M $70.67M
YoY Change 955.49% 1983.12% -48.23%
Income Tax $78.44M $93.72M $13.15M
% Of Pretax Income 10.52% 13.84% 18.61%
Net Earnings $667.4M $583.2M $57.52M
YoY Change 1060.39% -62.38% -55.32%
Net Earnings / Revenue 43.39% 41.27% 6.06%
Basic Earnings Per Share $2.56 $2.26 $0.22
Diluted Earnings Per Share $2.53 $2.23 $0.22
COMMON SHARES
Basic Shares Outstanding 260.4M shares 258.0M shares 256.9M shares
Diluted Shares Outstanding 264.1M shares 262.1M shares 260.5M shares

Balance Sheet

Concept 2020 Q3 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.151B $3.808B $3.996B
YoY Change 53.93% 20.2% 30.76%
Cash & Equivalents $5.358B $3.109B $3.398B
Short-Term Investments $793.0M $699.0M $598.0M
Other Short-Term Assets $270.0M $214.0M $175.0M
YoY Change 54.29% 247.45% 37.8%
Inventory $245.5M $167.5M $162.3M
Prepaid Expenses
Receivables $791.9M $633.5M $443.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.458B $4.823B $4.777B
YoY Change 56.13% 25.49% 29.58%
LONG-TERM ASSETS
Property, Plant & Equipment $920.9M $745.1M $733.5M
YoY Change 25.55% -8.24% -9.26%
Goodwill $1.002B $1.000B $447.5M
YoY Change 123.93% 1884.13% 787.95%
Intangibles $400.0M $400.0M
YoY Change
Long-Term Investments $21.00M
YoY Change
Other Assets $372.3M $69.38M $79.99M
YoY Change 365.45% 70.35% 72.04%
Total Long-Term Assets $3.843B $3.496B $2.737B
YoY Change 40.39% 45.48% 193.02%
TOTAL ASSETS
Total Short-Term Assets $7.458B $4.823B $4.777B
Total Long-Term Assets $3.843B $3.496B $2.737B
Total Assets $11.30B $8.318B $7.515B
YoY Change 50.4% 33.18% 62.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $107.8M $87.61M $92.53M
YoY Change 16.49% -21.06% 0.41%
Accrued Expenses $1.704B $1.117B $1.174B
YoY Change 45.15% 16.48% 132.78%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $30.00M $37.00M
YoY Change 200.0% 208.33%
Total Short-Term Liabilities $2.004B $1.335B $1.389B
YoY Change 44.29% 19.15% 39.94%
LONG-TERM LIABILITIES
Long-Term Debt $547.0M $539.0M $542.0M
YoY Change 0.92% -7.39% -6.07%
Other Long-Term Liabilities $428.5M $99.03M $7.642M
YoY Change 5507.43% -9.03% -70.94%
Total Long-Term Liabilities $428.5M $99.03M $7.642M
YoY Change 5507.43% -9.03% -70.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.004B $1.335B $1.389B
Total Long-Term Liabilities $428.5M $99.03M $7.642M
Total Liabilities $3.168B $2.233B $2.261B
YoY Change 40.11% 23.34% 34.09%
SHAREHOLDERS EQUITY
Retained Earnings $254.5M -$1.853B -$2.436B
YoY Change -110.45% -38.02% -46.34%
Common Stock $7.920B $7.940B $7.671B
YoY Change 3.25% 6.95% 3.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.133B $6.085B $5.253B
YoY Change
Total Liabilities & Shareholders Equity $11.30B $8.318B $7.515B
YoY Change 50.4% 33.18% 62.62%

Cashflow Statement

Concept 2020 Q3 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income $667.4M $583.2M $57.52M
YoY Change 1060.39% -62.38% -55.32%
Depreciation, Depletion And Amortization $26.70M $26.20M $25.90M
YoY Change 3.09% 39.36% 34.9%
Cash From Operating Activities $907.8M $446.0M $334.8M
YoY Change 171.15% 41.77% -12.2%
INVESTING ACTIVITIES
Capital Expenditures -$174.8M -$16.80M -$24.30M
YoY Change 619.34% 7.01% 16.27%
Acquisitions
YoY Change
Other Investing Activities -$73.10M -$880.3M -$224.7M
YoY Change -67.47% 3407.17% 674.83%
Cash From Investing Activities -$248.0M -$897.0M -$249.0M
YoY Change -0.4% 2093.15% 399.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -140.7M 161.4M 20.40M
YoY Change -789.71% -259.8% 871.43%
NET CHANGE
Cash From Operating Activities 907.8M 446.0M 334.8M
Cash From Investing Activities -248.0M -897.0M -249.0M
Cash From Financing Activities -140.7M 161.4M 20.40M
Net Change In Cash 519.1M -289.6M 106.2M
YoY Change 388.79% -267.69% -68.16%
FREE CASH FLOW
Cash From Operating Activities $907.8M $446.0M $334.8M
Capital Expenditures -$174.8M -$16.80M -$24.30M
Free Cash Flow $1.083B $462.8M $359.1M
YoY Change 201.48% 40.12% -10.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
VERTEX PHARMACEUTICALS INC / MA
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Central Index Key
EntityCentralIndexKey
0000875320
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201602Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity File Number
EntityFileNumber
000-19319
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MA
dei Entity Address Address Line1
EntityAddressAddressLine1
50 Northern Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
Boston
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3039129
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02210
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
341-6100
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
672241000 USD
dei Security12b Title
Security12bTitle
Common Stock, $0.01 Par Value Per Share
dei Trading Symbol
TradingSymbol
VRTX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
260037894 shares
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1538271000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
949828000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4577863000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2749556000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
186182000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
131914000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
533199000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
362746000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
493497000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
555948000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1362953000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1274529000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
184551000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
159674000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
558613000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
463221000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1800000 USD
CY2019Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2959000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12600000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2959000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
866030000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
850495000 USD
us-gaap Costs And Expenses
CostsAndExpenses
2467365000 USD
us-gaap Costs And Expenses
CostsAndExpenses
2103455000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
99333000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
2110498000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
646101000 USD
CY2020Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
3100000 USD
CY2019Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
17628000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
19919000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
51319000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-13856000 USD
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-14548000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-41863000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-44253000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
84386000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-31747000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
139621000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64802000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
745871000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
70666000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2228175000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
717969000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78437000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13148000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
120718000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
124393000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
667434000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
57518000 USD
us-gaap Net Income Loss
NetIncomeLoss
2107457000 USD
us-gaap Net Income Loss
NetIncomeLoss
593576000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.56
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.32
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.53
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
18188000 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.28
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
260392000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
256946000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
260313000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
256289000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
264079000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
260473000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
264031000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
260182000 shares
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
667434000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
57518000 USD
us-gaap Net Income Loss
NetIncomeLoss
2107457000 USD
us-gaap Net Income Loss
NetIncomeLoss
593576000 USD
CY2020Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1132000 USD
CY2019Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
64000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
818000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-26313000 USD
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1111000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
7600000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
2200000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
7300000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
5500000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
12812000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-27211000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
6814000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
584000 USD
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
9172000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-12616000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
10263000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-26861000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
22048000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-39009000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
640573000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
79566000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2068448000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
611764000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5358087000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3109322000 USD
CY2020Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
792971000 USD
CY2019Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
698972000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
791917000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
633518000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
245460000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
167502000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
270021000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
213515000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
7458456000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
4822829000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
192541000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
130305000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
920913000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
745080000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
1002158000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1002158000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
400000000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
400000000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1147816000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1190815000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
372290000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
157583000 USD
CY2020Q3 us-gaap Assets
Assets
11301633000 USD
CY2019Q4 us-gaap Assets
Assets
8318465000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
107786000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
87610000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1703699000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1116912000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2004026000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1334827000 USD
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
546514000 USD
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
538576000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
189100000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
176500000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
428520000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
183318000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
3168160000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
2233221000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
260174000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
260174000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
258993000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
258993000 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
2601000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
2589000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
7917375000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
7937606000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-40982000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1973000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
254479000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1852978000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
8133473000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
6085244000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11301633000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8318465000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
5069965000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
22048000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
57518000 USD
CY2019Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
12001000 USD
CY2019Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
104000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
30012000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85956000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
5253394000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
7519242000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-26861000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
667434000 USD
CY2020Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
108007000 USD
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
40528000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
21704000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
100489000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
8133473000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
4435203000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
18188000 USD
us-gaap Net Income Loss
NetIncomeLoss
593576000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
162018000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5936000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
144557000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
270134000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
5253394000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
6085244000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-39009000 USD
us-gaap Net Income Loss
NetIncomeLoss
2107457000 USD
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
408033000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
179775000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
232079000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
335510000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
8133473000 USD
us-gaap Net Income Loss
NetIncomeLoss
2107457000 USD
us-gaap Net Income Loss
NetIncomeLoss
593576000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
332434000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
268898000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
80160000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
80685000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12600000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2959000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
65110000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
94175000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
140866000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
68862000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-52371000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
4024000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
151191000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
41444000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
94907000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
45280000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
264909000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
23709000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16153000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-12210000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
451084000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-144359000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
255699000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
296477000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
22859000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2761973000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1123322000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
246937000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
381739000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
184419000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
375145000 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
149595000 USD
us-gaap Proceeds From Sale And Maturity Of Other Investments
ProceedsFromSaleAndMaturityOfOtherInvestments
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
245824000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
212109000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58690000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
19327000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
27219000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-338327000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
234854000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
144630000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
408033000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
150017000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
179775000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5936000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
31378000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
28879000 USD
vrtx Proceeds From Finance Leases
ProceedsFromFinanceLeases
8642000 USD
vrtx Proceeds From Finance Leases
ProceedsFromFinanceLeases
1002000 USD
vrtx Proceeds From Collaborative Funding
ProceedsFromCollaborativeFunding
5000000 USD
vrtx Proceeds From Collaborative Funding
ProceedsFromCollaborativeFunding
10000000 USD
vrtx Repaymentsof Collaborative Funding
RepaymentsofCollaborativeFunding
2741000 USD
vrtx Repaymentsof Collaborative Funding
RepaymentsofCollaborativeFunding
4316000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-6658000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1132000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-380089000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34648000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2779000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4009000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2240304000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
746338000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3120681000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2658253000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5360985000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3404591000 USD
us-gaap Interest Paid Net
InterestPaidNet
40769000 USD
us-gaap Interest Paid Net
InterestPaidNet
41704000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
81684000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
22838000 USD
vrtx Employee Benefit Plan Payable Receivable
EmployeeBenefitPlanPayableReceivable
45000 USD
vrtx Employee Benefit Plan Payable Receivable
EmployeeBenefitPlanPayableReceivable
13000 USD
vrtx Accrued Share Repurchase Liability
AccruedShareRepurchaseLiability
0 USD
vrtx Accrued Share Repurchase Liability
AccruedShareRepurchaseLiability
12001000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the amounts of revenues and expenses during the reported periods. Significant estimates in these condensed consolidated financial statements have been made in connection with (i) determining the transaction price of revenues and (ii) accounting for intangible assets and contingent consideration. The Company bases its estimates on historical experience and various other assumptions, including in certain circumstances future projections that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</span></div>
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1538271000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
949828000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4577863000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2749556000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
94800000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
62300000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
667434000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
57518000 USD
us-gaap Net Income Loss
NetIncomeLoss
2107457000 USD
us-gaap Net Income Loss
NetIncomeLoss
593576000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
260392000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
256946000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
260313000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
256289000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
12000 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
13000 shares
us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
17000 shares
us-gaap Incremental Common Shares Attributable To Equity Unit Purchase Agreements
IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements
14000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
264079000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
260473000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
264031000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
260182000 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.56
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.32
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.53
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.98
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.28
CY2020Q3 us-gaap Cash
Cash
2200000000 USD
CY2019Q4 us-gaap Cash
Cash
2300000000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
176500000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12600000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
189100000 USD
CY2020Q3 us-gaap Cash
Cash
2200000000 USD
CY2019Q4 us-gaap Cash
Cash
2300000000 USD
CY2020Q3 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
103463000 USD
us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
209219000 USD
us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
0 USD
CY2020Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
312682000 USD
CY2019Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
113829000 USD
CY2019 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
168255000 USD
CY2019 us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
0 USD
CY2019Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
282084000 USD
CY2020Q3 vrtx Debtand Equity Securities Cost
DebtandEquitySecuritiesCost
582432000 USD
CY2020Q3 vrtx Debtand Equity Securities Unrealized Gain
DebtandEquitySecuritiesUnrealizedGain
210561000 USD
CY2020Q3 vrtx Debtand Equity Securities Unrealized Loss
DebtandEquitySecuritiesUnrealizedLoss
22000 USD
CY2020Q3 vrtx Debtand Equity Securities Fair Value
DebtandEquitySecuritiesFairValue
792971000 USD
CY2019Q4 vrtx Debtand Equity Securities Cost
DebtandEquitySecuritiesCost
530216000 USD
CY2019Q4 vrtx Debtand Equity Securities Unrealized Gain
DebtandEquitySecuritiesUnrealizedGain
168811000 USD
CY2019Q4 vrtx Debtand Equity Securities Unrealized Loss
DebtandEquitySecuritiesUnrealizedLoss
55000 USD
CY2019Q4 vrtx Debtand Equity Securities Fair Value
DebtandEquitySecuritiesFairValue
698972000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3615654000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1243469000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
3514474000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1137942000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
101180000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
105527000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
3615654000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1243469000 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2019Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2020Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0 USD
CY2020Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
69800000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
102300000 USD
CY2019Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-31200000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
68900000 USD
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-32711000 USD
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
6298000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-39009000 USD
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
38037000 USD
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
19849000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
18188000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
84386000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-31747000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
139621000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64802000 USD
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
42542000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
26247000 USD
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
135220000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
107021000 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
67698000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
34234000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
245460000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
167502000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
950000 USD
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
99539000 USD
CY2019Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
536000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3076000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
1236000 USD
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
85420000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
332434000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
268898000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
99539000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
85420000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
332434000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
268898000 USD
CY2020Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
35295000 USD
CY2019Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
21996000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
130692000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
87638000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
64244000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
63424000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
201742000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
181260000 USD
CY2020Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4378000 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y7M17D
CY2020Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
140.26
CY2020Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2747000 shares
CY2020Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
123.22
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
120700000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
124400000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-209000000.0 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
205200000 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
73800000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
33900000 USD
vrtx Number Of Credit Agreements
NumberOfCreditAgreements
2 credit_agreement
CY2020Q3 vrtx Indemnification Claims
IndemnificationClaims
0 USD
CY2020Q3 vrtx Contingent Liabilities
ContingentLiabilities
0 USD
CY2019Q4 vrtx Contingent Liabilities
ContingentLiabilities
0 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3109322000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5358087000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2650134000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3397941000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3120681000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5360985000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2658253000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3404591000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
256800000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
268500000 USD

Files In Submission

Name View Source Status
0000875320-20-000043-index-headers.html Edgar Link pending
0000875320-20-000043-index.html Edgar Link pending
0000875320-20-000043.txt Edgar Link pending
0000875320-20-000043-xbrl.zip Edgar Link pending
a2020q310-qexhibit101.htm Edgar Link pending
a2020q310-qexhibit311.htm Edgar Link pending
a2020q310-qexhibit312.htm Edgar Link pending
a2020q310-qexhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrtx-20200930.htm Edgar Link pending
vrtx-20200930.xsd Edgar Link pending
vrtx-20200930_cal.xml Edgar Link unprocessable
vrtx-20200930_def.xml Edgar Link unprocessable
vrtx-20200930_g1.jpg Edgar Link pending
vrtx-20200930_g2.jpg Edgar Link pending
vrtx-20200930_htm.xml Edgar Link completed
vrtx-20200930_lab.xml Edgar Link unprocessable
vrtx-20200930_pre.xml Edgar Link unprocessable